From January 18, 2024 to March 31, 2024, the company has repurchased 2,476,300 shares, representing 0.27% for HKD 60.36 million. With this, the company has completed the repurchase of 2,476,300 shares, representing 0.27% for HKD 60.36 million under the buyback announced on January 19, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.81 CNY | +2.47% | +2.00% | +13.71% |
May. 27 | Livzon Pharmaceutical Cancels 5.3 Million Share Options | MT |
May. 14 | Livzon Pharmaceutical Group Cancels Share Options | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.71% | 4.46B | |
+42.83% | 750B | |
+34.11% | 606B | |
-5.70% | 356B | |
+18.06% | 326B | |
+4.63% | 286B | |
+18.25% | 246B | |
+11.09% | 213B | |
-2.90% | 213B | |
+2.43% | 167B |
- Stock Market
- Equities
- 000513 Stock
- News Livzon Pharmaceutical Group Inc.
- Tranche Update on Livzon Pharmaceutical Group Inc.'s Equity Buyback Plan announced on January 19, 2024.